Navigation Links
Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies
Date:6/16/2008

Olympus Corporation to Support the Joint Program through the Provision of

Novel Imaging Systems Collaboration Will Bring Innovative Fluorescent Imaging Agent and System

Technologies into Clinical Trials in Ovarian Cancer

PHILADELPHIA, TOKYO and WOBURN, Mass, June 16 /PRNewswire/ -- Fox Chase Cancer Center and VisEn Medical today announced a partnership to advance Phase I clinical trials of one of VisEn Medical's "smart" fluorescence activatable imaging agents to enable physicians to identify and characterize early stage disease in oncology patients. Olympus Medical Systems Corp. will provide paired fluorescence laparoscopic imaging systems to enable the detection and evaluation of ProSense highlighted tumors in patients in the trials. The clinical trials will initially focus on ovarian cancer and are planned to begin in 2009 at Fox Chase Cancer Center.

Under terms of the program, VisEn will develop and submit an Investigational New Drug (IND) application on a clinical analog of its proprietary fluorescence molecular imaging agent, ProSense(R), which highlights certain enzymatic processes associated with early stage cancer development in vivo. In addition to conducting the clinical trials, Fox Chase Cancer Center will invest in the ProSense clinical program through VisEn and will receive certain rights, equity and royalties on future sales.

"These clinical molecular imaging technologies should provide the foundations for earlier and more accurate disease detection, and more importantly, enhanced functional imaging capabilities that will eventually help guide therapeutic interventions," said Michael V. Seiden, MD, Ph.D., President and CEO of Fox Chase Cancer Center. "Promoting advances in diagnosis that may lead to improved cancer treatments is a key part of Fox Chase's approach to solving the cancer problem, and we are pleased to be working with two of the leaders in molecular imaging to help bring
'/>"/>

SOURCE VisEn Medical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKlines Rotarix(R)
2. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
4. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
5. New Meta-Analysis Confirms Safety Profile for NeoRecormon in Treating Anaemia in Cancer Patients
6. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
7. Rosetta Genomics and M. D. Anderson to Develop a MicroRNA-based Diagnostic Test to Identify Risk of Recurrence of Lung Cancer
8. Ending Cervical Cancer Featured at Summit; QIAGEN CEO Issues a Call to Global Women Leaders
9. Leading Academic Institutions Collaborate on 800-Patient Study of Effectiveness of Cryoablation for Men With Recurrent Prostate Cancer
10. BN ImmunoTherapeutics Starts Clinical Trials With Prostate Cancer Vaccine
11. Celator(R) Pharmaceuticals Announces Positive Phase 2 Results for CPX-1 in Treatment of Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)..., LOVELAND,Colo.,Nov.25/PRNewswire-FirstCall/--He... advanceddiagnosticandspecialtyproductstotheveteri...nosticsCorporationforthesupplyofbloodgasproductsan..., (Logo: http://www.newscom.com/cgi-bin/prnh/20000...ssionforinnovatinginthefieldofadvancedpoint-of-car...
(Date:11/25/2009)..., EXTON,Pa.,Nov.25/PRNewswire/--BioTrendsResearch... Stelara report,thefirstinamulti-phasesyndicatedm...ho-Biotech,sStelara,fromproductlaunchthroughthefir...desquantitativeinformationfrom75uniqueDermatologis...rtsassesstrialanduseofStelara,obstaclestouse,typic...
(Date:11/25/2009)..., BASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBio...tofantithromboticaptamerswithactivecontrolagents,a...resentingatthePiperJaffray21stAnnualHealthCareConf...o,spresentationwillbegivenat1:10pm(EST)onTuesday,D...linewithemphasisontheleaddevelopmentprogram,theant...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Firm Parents Keep Teen Drivers Safe 58357 1Firm Parents Keep Teen Drivers Safe 58357 2Firm Parents Keep Teen Drivers Safe 58357 3Loyola University Chicago awarded scholarships for accelerated nursing students 58354 1Loyola University Chicago awarded scholarships for accelerated nursing students 58354 2M D Anderson scientist wins NIH New Innovator Award 58351 1M D Anderson scientist wins NIH New Innovator Award 58351 2M D Anderson scientist wins NIH New Innovator Award 58351 3
...in treating pediatric acute lymphoblastic,leukemia...ians treat,adolescents and adults with the disease... that has occurred in the cure rate for children w...ficult to replicate in older,patients without cons...cle,by St. Jude Children,s Research Hospital autho...
... NanoBio Corporation,announced today that it has ... its phase 2 study of NB-002, a topical lotion for... remain confidential, the results clearly,justify ...sts., "Allowing adequate time for subjects to gro... infection will enable us to generate data on,comp...
Other Medicine Technology:Molecular Science Could Further Improve Leukemia Survival, Say St. Jude Researchers 2NanoBio Corporation Completes Interim Analysis of Phase 2 Clinical Trial in Onychomycosis 2
(Date:11/26/2009)...on an emotional rollercoaster, study finds , ...it the fear factor meets the jubilant sports fan. ...ially those who root for the winning team -- enjoy...sted match and victory was in doubt, producing fee... this Thanksgiving weekend as you,re glued to the ...
(Date:11/26/2009)...s & Ennis, P.A. is offering free nationwide co...in birth control pills who have suffered a Deep Ve...eart Attack or other related cardiac issues or had...ee at 1-800-856-6405 or go to the firm’s web...online case evaluation form. , ...
(Date:11/25/2009)...ire/-SentinelleMedicalInc.,aleadingmanufacturerofb...hesasuiteofnewleadingedgeclinicalapplicationsonits...sRadiologicalSocietyofNorthAmerica(RSNA)annualmeet...eapplicationsleveragetheuniquehighqualityimagesgen...upportmultipleimagingmodalitiesformulti-parametric...
(Date:11/25/2009)...ments,Business,andPressJoinEfforttoEducate ,, ...gain,theNationalBipolarFoundationandtheMedicAlertF...ilStable"program,whichisnowbeingwidelyacceptedasap...,theNationalBipolarFoundationreceivedaproclamation...t.GovernorofLouisianaMitchLandrieu.TheNationalBipo...
(Date:11/25/2009)... too short to draw definite conclusions, experts s...ews) -- In diabetic patients with blocked coronary...tcomes at one year whether patients undergo bypass...earchers report. , Bypass surgery has been the ...nary artery disease. However, less invasive approa...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:Stenting May Equal Bypass for Diabetic Heart Patients 2Health News:Stenting May Equal Bypass for Diabetic Heart Patients 3
...One, the leading provider of integrated incentive ...is offering a "Flu Prevention Rewards Program...r, health plan and other health care provider spon...he leading provider of integrated incentive admini...
.... (Nasdaq:,EVVV) today announced that Pat Spangler...communications officer, are scheduled to present a...onference at 2:10 p.m. Eastern Time on,Tuesday, Se... to the investors, section of the ev3 Web site,at ...
...rd Hospital & Clinics,and Lucile Packard Children,...rdpackardfacts.com, an online resource regarding ..., "The interest in the English version of this We...to our,employees just made sense.", On Sept. 10 a...
...dicine Practice Guidelines offers more ..., Colo., Aug. 19 The American College of,Occupati...ished new medical,treatment guidelines for providi...e Practice Guidelines, are available online,now; i...
...ht be hazardous , , TUESDAY, Aug. 19 (Heal...acid and vitamin B supplements help the heart has ...ny good and might have even caused participants ha... raises a few red flags," said Alice H. Lichtenste...
...t for Potential to Control ,Super-Bug, ... SinoFresh HealthCare,Inc., (OTC Bulletin Board: ...uccessful in vivo pilot study indicating that its ...cientific model,intended to demonstrate SinoFresh(...
Other Medicine News:Health News:IncentOne Announces Flu Prevention Rewards Program™ 2Health News:ACOEM Chronic Pain Guidelines Now Available Online 2Health News:ACOEM Chronic Pain Guidelines Now Available Online 3Health News:Vitamin B, Folate Supplements Won't Help Heart 2Health News:Vitamin B, Folate Supplements Won't Help Heart 3Health News:SinoFresh(R) Nasal Spray Kills MRSA 'Super-Bug' in Live Noses 2Health News:SinoFresh(R) Nasal Spray Kills MRSA 'Super-Bug' in Live Noses 3
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
...erence laboratory and a worldwide leader in innova...ers an extensive test menu of highly complex and u...logy. Owned by the University of Utah, ARUP Labora...on's university teaching hospitals and children's ...
Medicine Products: